カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界の生体内薬理学市場予測2023-2029：動物疾患モデル、生体外薬理学およびバイオマーカー、PD/PK、その他

【英語タイトル】In Vivo Pharmacology Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23LY8808）・商品コード：MMG23LY8808
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：111
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の生体内薬理学市場規模と予測を収録しています。・世界の生体内薬理学市場：売上、2018年-2023年、2024年-2029年
・世界の生体内薬理学市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の生体内薬理学市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「動物疾患モデル」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

生体内薬理学のグローバル主要企業は、Charles River、 The Jackson Laboratory、 Syngene、 Evotec、 Pharmaron、 Aurigene Pharmaceutical、 Jubilant Biosys、 Labcorp、 Inotiv、 Takeda Pharmaceutical、 EXUMA Biotech、 Novartis、 Be Biopharma、 Alderley Oncology、 Sygnature Discovery、 GenScript ProBio、 Zai Lab、 Sinclair Research、 Eli Lilly、 Gubraなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、生体内薬理学のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の生体内薬理学市場：タイプ別、2018年-2023年、2024年-2029年
世界の生体内薬理学市場：タイプ別市場シェア、2022年
・動物疾患モデル、生体外薬理学およびバイオマーカー、PD/PK、その他

世界の生体内薬理学市場：用途別、2018年-2023年、2024年-2029年
世界の生体内薬理学市場：用途別市場シェア、2022年
・腫瘍学/免疫腫瘍学、代謝疾患、炎症性疾患、中枢神経系疾患

世界の生体内薬理学市場：地域・国別、2018年-2023年、2024年-2029年
世界の生体内薬理学市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における生体内薬理学のグローバル売上、2018年-2023年
・主要企業における生体内薬理学のグローバル売上シェア、2022年
・主要企業における生体内薬理学のグローバル販売量、2018年-2023年
・主要企業における生体内薬理学のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Charles River、 The Jackson Laboratory、 Syngene、 Evotec、 Pharmaron、 Aurigene Pharmaceutical、 Jubilant Biosys、 Labcorp、 Inotiv、 Takeda Pharmaceutical、 EXUMA Biotech、 Novartis、 Be Biopharma、 Alderley Oncology、 Sygnature Discovery、 GenScript ProBio、 Zai Lab、 Sinclair Research、 Eli Lilly、 Gubra

*************************************************************

・調査・分析レポートの概要
生体内薬理学市場の定義
市場セグメント
世界の生体内薬理学市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の生体内薬理学市場規模
世界の生体内薬理学市場規模：2022年 VS 2029年
世界の生体内薬理学市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの生体内薬理学の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の生体内薬理学製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：動物疾患モデル、生体外薬理学およびバイオマーカー、PD/PK、その他
生体内薬理学のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：腫瘍学/免疫腫瘍学、代謝疾患、炎症性疾患、中枢神経系疾患
生体内薬理学の用途別グローバル売上・予測

・地域別市場分析
地域別生体内薬理学市場規模 2022年と2029年
地域別生体内薬理学売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Charles River、 The Jackson Laboratory、 Syngene、 Evotec、 Pharmaron、 Aurigene Pharmaceutical、 Jubilant Biosys、 Labcorp、 Inotiv、 Takeda Pharmaceutical、 EXUMA Biotech、 Novartis、 Be Biopharma、 Alderley Oncology、 Sygnature Discovery、 GenScript ProBio、 Zai Lab、 Sinclair Research、 Eli Lilly、 Gubra
...

This report aims to provide a comprehensive presentation of the global market for In Vivo Pharmacology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vivo Pharmacology. This report contains market size and forecasts of In Vivo Pharmacology in global, including the following market information:
Global In Vivo Pharmacology Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global In Vivo Pharmacology market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Animal Disease Models Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of In Vivo Pharmacology include Charles River, The Jackson Laboratory, Syngene, Evotec, Pharmaron, Aurigene Pharmaceutical, Jubilant Biosys, Labcorp and Inotiv, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the In Vivo Pharmacology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global In Vivo Pharmacology Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global In Vivo Pharmacology Market Segment Percentages, by Type, 2022 (%)
Animal Disease Models
Ex Vivo Pharmacology & Biomarkers
PD/PK
Others
Global In Vivo Pharmacology Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global In Vivo Pharmacology Market Segment Percentages, by Application, 2022 (%)
Ncology/Immuno-oncology
Metabolic Disorders
Inflammatory Diseases
CNS Diseases
Global In Vivo Pharmacology Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global In Vivo Pharmacology Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies In Vivo Pharmacology revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies In Vivo Pharmacology revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Charles River
The Jackson Laboratory
Syngene
Evotec
Pharmaron
Aurigene Pharmaceutical
Jubilant Biosys
Labcorp
Inotiv
Takeda Pharmaceutical
EXUMA Biotech
Novartis
Be Biopharma
Alderley Oncology
Sygnature Discovery
GenScript ProBio
Zai Lab
Sinclair Research
Eli Lilly
Gubra
Outline of Major Chapters:
Chapter 1: Introduces the definition of In Vivo Pharmacology, market overview.
Chapter 2: Global In Vivo Pharmacology market size in revenue.
Chapter 3: Detailed analysis of In Vivo Pharmacology company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of In Vivo Pharmacology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 In Vivo Pharmacology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global In Vivo Pharmacology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global In Vivo Pharmacology Overall Market Size
2.1 Global In Vivo Pharmacology Market Size: 2022 VS 2029
2.2 Global In Vivo Pharmacology Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top In Vivo Pharmacology Players in Global Market
3.2 Top Global In Vivo Pharmacology Companies Ranked by Revenue
3.3 Global In Vivo Pharmacology Revenue by Companies
3.4 Top 3 and Top 5 In Vivo Pharmacology Companies in Global Market, by Revenue in 2022
3.5 Global Companies In Vivo Pharmacology Product Type
3.6 Tier 1, Tier 2 and Tier 3 In Vivo Pharmacology Players in Global Market
3.6.1 List of Global Tier 1 In Vivo Pharmacology Companies
3.6.2 List of Global Tier 2 and Tier 3 In Vivo Pharmacology Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global In Vivo Pharmacology Market Size Markets, 2022 & 2029
4.1.2 Animal Disease Models
4.1.3 Ex Vivo Pharmacology & Biomarkers
4.1.4 PD/PK
4.1.5 Others
4.2 By Type – Global In Vivo Pharmacology Revenue & Forecasts
4.2.1 By Type – Global In Vivo Pharmacology Revenue, 2018-2023
4.2.2 By Type – Global In Vivo Pharmacology Revenue, 2024-2029
4.2.3 By Type – Global In Vivo Pharmacology Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global In Vivo Pharmacology Market Size, 2022 & 2029
5.1.2 Ncology/Immuno-oncology
5.1.3 Metabolic Disorders
5.1.4 Inflammatory Diseases
5.1.5 CNS Diseases
5.2 By Application – Global In Vivo Pharmacology Revenue & Forecasts
5.2.1 By Application – Global In Vivo Pharmacology Revenue, 2018-2023
5.2.2 By Application – Global In Vivo Pharmacology Revenue, 2024-2029
5.2.3 By Application – Global In Vivo Pharmacology Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global In Vivo Pharmacology Market Size, 2022 & 2029
6.2 By Region – Global In Vivo Pharmacology Revenue & Forecasts
6.2.1 By Region – Global In Vivo Pharmacology Revenue, 2018-2023
6.2.2 By Region – Global In Vivo Pharmacology Revenue, 2024-2029
6.2.3 By Region – Global In Vivo Pharmacology Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America In Vivo Pharmacology Revenue, 2018-2029
6.3.2 US In Vivo Pharmacology Market Size, 2018-2029
6.3.3 Canada In Vivo Pharmacology Market Size, 2018-2029
6.3.4 Mexico In Vivo Pharmacology Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe In Vivo Pharmacology Revenue, 2018-2029
6.4.2 Germany In Vivo Pharmacology Market Size, 2018-2029
6.4.3 France In Vivo Pharmacology Market Size, 2018-2029
6.4.4 U.K. In Vivo Pharmacology Market Size, 2018-2029
6.4.5 Italy In Vivo Pharmacology Market Size, 2018-2029
6.4.6 Russia In Vivo Pharmacology Market Size, 2018-2029
6.4.7 Nordic Countries In Vivo Pharmacology Market Size, 2018-2029
6.4.8 Benelux In Vivo Pharmacology Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia In Vivo Pharmacology Revenue, 2018-2029
6.5.2 China In Vivo Pharmacology Market Size, 2018-2029
6.5.3 Japan In Vivo Pharmacology Market Size, 2018-2029
6.5.4 South Korea In Vivo Pharmacology Market Size, 2018-2029
6.5.5 Southeast Asia In Vivo Pharmacology Market Size, 2018-2029
6.5.6 India In Vivo Pharmacology Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America In Vivo Pharmacology Revenue, 2018-2029
6.6.2 Brazil In Vivo Pharmacology Market Size, 2018-2029
6.6.3 Argentina In Vivo Pharmacology Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa In Vivo Pharmacology Revenue, 2018-2029
6.7.2 Turkey In Vivo Pharmacology Market Size, 2018-2029
6.7.3 Israel In Vivo Pharmacology Market Size, 2018-2029
6.7.4 Saudi Arabia In Vivo Pharmacology Market Size, 2018-2029
6.7.5 UAE In Vivo Pharmacology Market Size, 2018-2029
7 In Vivo Pharmacology Companies Profiles
7.1 Charles River
7.1.1 Charles River Company Summary
7.1.2 Charles River Business Overview
7.1.3 Charles River In Vivo Pharmacology Major Product Offerings
7.1.4 Charles River In Vivo Pharmacology Revenue in Global Market (2018-2023)
7.1.5 Charles River Key News & Latest Developments
7.2 The Jackson Laboratory
7.2.1 The Jackson Laboratory Company Summary
7.2.2 The Jackson Laboratory Business Overview
7.2.3 The Jackson Laboratory In Vivo Pharmacology Major Product Offerings
7.2.4 The Jackson Laboratory In Vivo Pharmacology Revenue in Global Market (2018-2023)
7.2.5 The Jackson Laboratory Key News & Latest Developments
7.3 Syngene
7.3.1 Syngene Company Summary
7.3.2 Syngene Business Overview
7.3.3 Syngene In Vivo Pharmacology Major Product Offerings
7.3.4 Syngene In Vivo Pharmacology Revenue in Global Market (2018-2023)
7.3.5 Syngene Key News & Latest Developments
7.4 Evotec
7.4.1 Evotec Company Summary
7.4.2 Evotec Business Overview
7.4.3 Evotec In Vivo Pharmacology Major Product Offerings
7.4.4 Evotec In Vivo Pharmacology Revenue in Global Market (2018-2023)
7.4.5 Evotec Key News & Latest Developments
7.5 Pharmaron
7.5.1 Pharmaron Company Summary
7.5.2 Pharmaron Business Overview
7.5.3 Pharmaron In Vivo Pharmacology Major Product Offerings
7.5.4 Pharmaron In Vivo Pharmacology Revenue in Global Market (2018-2023)
7.5.5 Pharmaron Key News & Latest Developments
7.6 Aurigene Pharmaceutical
7.6.1 Aurigene Pharmaceutical Company Summary
7.6.2 Aurigene Pharmaceutical Business Overview
7.6.3 Aurigene Pharmaceutical In Vivo Pharmacology Major Product Offerings
7.6.4 Aurigene Pharmaceutical In Vivo Pharmacology Revenue in Global Market (2018-2023)
7.6.5 Aurigene Pharmaceutical Key News & Latest Developments
7.7 Jubilant Biosys
7.7.1 Jubilant Biosys Company Summary
7.7.2 Jubilant Biosys Business Overview
7.7.3 Jubilant Biosys In Vivo Pharmacology Major Product Offerings
7.7.4 Jubilant Biosys In Vivo Pharmacology Revenue in Global Market (2018-2023)
7.7.5 Jubilant Biosys Key News & Latest Developments
7.8 Labcorp
7.8.1 Labcorp Company Summary
7.8.2 Labcorp Business Overview
7.8.3 Labcorp In Vivo Pharmacology Major Product Offerings
7.8.4 Labcorp In Vivo Pharmacology Revenue in Global Market (2018-2023)
7.8.5 Labcorp Key News & Latest Developments
7.9 Inotiv
7.9.1 Inotiv Company Summary
7.9.2 Inotiv Business Overview
7.9.3 Inotiv In Vivo Pharmacology Major Product Offerings
7.9.4 Inotiv In Vivo Pharmacology Revenue in Global Market (2018-2023)
7.9.5 Inotiv Key News & Latest Developments
7.10 Takeda Pharmaceutical
7.10.1 Takeda Pharmaceutical Company Summary
7.10.2 Takeda Pharmaceutical Business Overview
7.10.3 Takeda Pharmaceutical In Vivo Pharmacology Major Product Offerings
7.10.4 Takeda Pharmaceutical In Vivo Pharmacology Revenue in Global Market (2018-2023)
7.10.5 Takeda Pharmaceutical Key News & Latest Developments
7.11 EXUMA Biotech
7.11.1 EXUMA Biotech Company Summary
7.11.2 EXUMA Biotech Business Overview
7.11.3 EXUMA Biotech In Vivo Pharmacology Major Product Offerings
7.11.4 EXUMA Biotech In Vivo Pharmacology Revenue in Global Market (2018-2023)
7.11.5 EXUMA Biotech Key News & Latest Developments
7.12 Novartis
7.12.1 Novartis Company Summary
7.12.2 Novartis Business Overview
7.12.3 Novartis In Vivo Pharmacology Major Product Offerings
7.12.4 Novartis In Vivo Pharmacology Revenue in Global Market (2018-2023)
7.12.5 Novartis Key News & Latest Developments
7.13 Be Biopharma
7.13.1 Be Biopharma Company Summary
7.13.2 Be Biopharma Business Overview
7.13.3 Be Biopharma In Vivo Pharmacology Major Product Offerings
7.13.4 Be Biopharma In Vivo Pharmacology Revenue in Global Market (2018-2023)
7.13.5 Be Biopharma Key News & Latest Developments
7.14 Alderley Oncology
7.14.1 Alderley Oncology Company Summary
7.14.2 Alderley Oncology Business Overview
7.14.3 Alderley Oncology In Vivo Pharmacology Major Product Offerings
7.14.4 Alderley Oncology In Vivo Pharmacology Revenue in Global Market (2018-2023)
7.14.5 Alderley Oncology Key News & Latest Developments
7.15 Sygnature Discovery
7.15.1 Sygnature Discovery Company Summary
7.15.2 Sygnature Discovery Business Overview
7.15.3 Sygnature Discovery In Vivo Pharmacology Major Product Offerings
7.15.4 Sygnature Discovery In Vivo Pharmacology Revenue in Global Market (2018-2023)
7.15.5 Sygnature Discovery Key News & Latest Developments
7.16 GenScript ProBio
7.16.1 GenScript ProBio Company Summary
7.16.2 GenScript ProBio Business Overview
7.16.3 GenScript ProBio In Vivo Pharmacology Major Product Offerings
7.16.4 GenScript ProBio In Vivo Pharmacology Revenue in Global Market (2018-2023)
7.16.5 GenScript ProBio Key News & Latest Developments
7.17 Zai Lab
7.17.1 Zai Lab Company Summary
7.17.2 Zai Lab Business Overview
7.17.3 Zai Lab In Vivo Pharmacology Major Product Offerings
7.17.4 Zai Lab In Vivo Pharmacology Revenue in Global Market (2018-2023)
7.17.5 Zai Lab Key News & Latest Developments
7.18 Sinclair Research
7.18.1 Sinclair Research Company Summary
7.18.2 Sinclair Research Business Overview
7.18.3 Sinclair Research In Vivo Pharmacology Major Product Offerings
7.18.4 Sinclair Research In Vivo Pharmacology Revenue in Global Market (2018-2023)
7.18.5 Sinclair Research Key News & Latest Developments
7.19 Eli Lilly
7.19.1 Eli Lilly Company Summary
7.19.2 Eli Lilly Business Overview
7.19.3 Eli Lilly In Vivo Pharmacology Major Product Offerings
7.19.4 Eli Lilly In Vivo Pharmacology Revenue in Global Market (2018-2023)
7.19.5 Eli Lilly Key News & Latest Developments
7.20 Gubra
7.20.1 Gubra Company Summary
7.20.2 Gubra Business Overview
7.20.3 Gubra In Vivo Pharmacology Major Product Offerings
7.20.4 Gubra In Vivo Pharmacology Revenue in Global Market (2018-2023)
7.20.5 Gubra Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. In Vivo Pharmacology Market Opportunities & Trends in Global Market
Table 2. In Vivo Pharmacology Market Drivers in Global Market
Table 3. In Vivo Pharmacology Market Restraints in Global Market
Table 4. Key Players of In Vivo Pharmacology in Global Market
Table 5. Top In Vivo Pharmacology Players in Global Market, Ranking by Revenue (2022)
Table 6. Global In Vivo Pharmacology Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global In Vivo Pharmacology Revenue Share by Companies, 2018-2023
Table 8. Global Companies In Vivo Pharmacology Product Type
Table 9. List of Global Tier 1 In Vivo Pharmacology Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 In Vivo Pharmacology Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global In Vivo Pharmacology Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - In Vivo Pharmacology Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - In Vivo Pharmacology Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global In Vivo Pharmacology Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - In Vivo Pharmacology Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - In Vivo Pharmacology Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global In Vivo Pharmacology Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global In Vivo Pharmacology Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global In Vivo Pharmacology Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America In Vivo Pharmacology Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America In Vivo Pharmacology Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe In Vivo Pharmacology Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe In Vivo Pharmacology Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia In Vivo Pharmacology Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia In Vivo Pharmacology Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America In Vivo Pharmacology Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America In Vivo Pharmacology Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa In Vivo Pharmacology Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa In Vivo Pharmacology Revenue, (US$, Mn), 2024-2029
Table 30. Charles River Company Summary
Table 31. Charles River In Vivo Pharmacology Product Offerings
Table 32. Charles River In Vivo Pharmacology Revenue (US$, Mn) & (2018-2023)
Table 33. Charles River Key News & Latest Developments
Table 34. The Jackson Laboratory Company Summary
Table 35. The Jackson Laboratory In Vivo Pharmacology Product Offerings
Table 36. The Jackson Laboratory In Vivo Pharmacology Revenue (US$, Mn) & (2018-2023)
Table 37. The Jackson Laboratory Key News & Latest Developments
Table 38. Syngene Company Summary
Table 39. Syngene In Vivo Pharmacology Product Offerings
Table 40. Syngene In Vivo Pharmacology Revenue (US$, Mn) & (2018-2023)
Table 41. Syngene Key News & Latest Developments
Table 42. Evotec Company Summary
Table 43. Evotec In Vivo Pharmacology Product Offerings
Table 44. Evotec In Vivo Pharmacology Revenue (US$, Mn) & (2018-2023)
Table 45. Evotec Key News & Latest Developments
Table 46. Pharmaron Company Summary
Table 47. Pharmaron In Vivo Pharmacology Product Offerings
Table 48. Pharmaron In Vivo Pharmacology Revenue (US$, Mn) & (2018-2023)
Table 49. Pharmaron Key News & Latest Developments
Table 50. Aurigene Pharmaceutical Company Summary
Table 51. Aurigene Pharmaceutical In Vivo Pharmacology Product Offerings
Table 52. Aurigene Pharmaceutical In Vivo Pharmacology Revenue (US$, Mn) & (2018-2023)
Table 53. Aurigene Pharmaceutical Key News & Latest Developments
Table 54. Jubilant Biosys Company Summary
Table 55. Jubilant Biosys In Vivo Pharmacology Product Offerings
Table 56. Jubilant Biosys In Vivo Pharmacology Revenue (US$, Mn) & (2018-2023)
Table 57. Jubilant Biosys Key News & Latest Developments
Table 58. Labcorp Company Summary
Table 59. Labcorp In Vivo Pharmacology Product Offerings
Table 60. Labcorp In Vivo Pharmacology Revenue (US$, Mn) & (2018-2023)
Table 61. Labcorp Key News & Latest Developments
Table 62. Inotiv Company Summary
Table 63. Inotiv In Vivo Pharmacology Product Offerings
Table 64. Inotiv In Vivo Pharmacology Revenue (US$, Mn) & (2018-2023)
Table 65. Inotiv Key News & Latest Developments
Table 66. Takeda Pharmaceutical Company Summary
Table 67. Takeda Pharmaceutical In Vivo Pharmacology Product Offerings
Table 68. Takeda Pharmaceutical In Vivo Pharmacology Revenue (US$, Mn) & (2018-2023)
Table 69. Takeda Pharmaceutical Key News & Latest Developments
Table 70. EXUMA Biotech Company Summary
Table 71. EXUMA Biotech In Vivo Pharmacology Product Offerings
Table 72. EXUMA Biotech In Vivo Pharmacology Revenue (US$, Mn) & (2018-2023)
Table 73. EXUMA Biotech Key News & Latest Developments
Table 74. Novartis Company Summary
Table 75. Novartis In Vivo Pharmacology Product Offerings
Table 76. Novartis In Vivo Pharmacology Revenue (US$, Mn) & (2018-2023)
Table 77. Novartis Key News & Latest Developments
Table 78. Be Biopharma Company Summary
Table 79. Be Biopharma In Vivo Pharmacology Product Offerings
Table 80. Be Biopharma In Vivo Pharmacology Revenue (US$, Mn) & (2018-2023)
Table 81. Be Biopharma Key News & Latest Developments
Table 82. Alderley Oncology Company Summary
Table 83. Alderley Oncology In Vivo Pharmacology Product Offerings
Table 84. Alderley Oncology In Vivo Pharmacology Revenue (US$, Mn) & (2018-2023)
Table 85. Alderley Oncology Key News & Latest Developments
Table 86. Sygnature Discovery Company Summary
Table 87. Sygnature Discovery In Vivo Pharmacology Product Offerings
Table 88. Sygnature Discovery In Vivo Pharmacology Revenue (US$, Mn) & (2018-2023)
Table 89. Sygnature Discovery Key News & Latest Developments
Table 90. GenScript ProBio Company Summary
Table 91. GenScript ProBio In Vivo Pharmacology Product Offerings
Table 92. GenScript ProBio In Vivo Pharmacology Revenue (US$, Mn) & (2018-2023)
Table 93. GenScript ProBio Key News & Latest Developments
Table 94. Zai Lab Company Summary
Table 95. Zai Lab In Vivo Pharmacology Product Offerings
Table 96. Zai Lab In Vivo Pharmacology Revenue (US$, Mn) & (2018-2023)
Table 97. Zai Lab Key News & Latest Developments
Table 98. Sinclair Research Company Summary
Table 99. Sinclair Research In Vivo Pharmacology Product Offerings
Table 100. Sinclair Research In Vivo Pharmacology Revenue (US$, Mn) & (2018-2023)
Table 101. Sinclair Research Key News & Latest Developments
Table 102. Eli Lilly Company Summary
Table 103. Eli Lilly In Vivo Pharmacology Product Offerings
Table 104. Eli Lilly In Vivo Pharmacology Revenue (US$, Mn) & (2018-2023)
Table 105. Eli Lilly Key News & Latest Developments
Table 106. Gubra Company Summary
Table 107. Gubra In Vivo Pharmacology Product Offerings
Table 108. Gubra In Vivo Pharmacology Revenue (US$, Mn) & (2018-2023)
Table 109. Gubra Key News & Latest Developments
List of Figures
Figure 1. In Vivo Pharmacology Segment by Type in 2022
Figure 2. In Vivo Pharmacology Segment by Application in 2022
Figure 3. Global In Vivo Pharmacology Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global In Vivo Pharmacology Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global In Vivo Pharmacology Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by In Vivo Pharmacology Revenue in 2022
Figure 8. By Type - Global In Vivo Pharmacology Revenue Market Share, 2018-2029
Figure 9. By Application - Global In Vivo Pharmacology Revenue Market Share, 2018-2029
Figure 10. By Type - Global In Vivo Pharmacology Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global In Vivo Pharmacology Revenue Market Share, 2018-2029
Figure 12. By Application - Global In Vivo Pharmacology Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global In Vivo Pharmacology Revenue Market Share, 2018-2029
Figure 14. By Region - Global In Vivo Pharmacology Revenue Market Share, 2018-2029
Figure 15. By Country - North America In Vivo Pharmacology Revenue Market Share, 2018-2029
Figure 16. US In Vivo Pharmacology Revenue, (US$, Mn), 2018-2029
Figure 17. Canada In Vivo Pharmacology Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico In Vivo Pharmacology Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe In Vivo Pharmacology Revenue Market Share, 2018-2029
Figure 20. Germany In Vivo Pharmacology Revenue, (US$, Mn), 2018-2029
Figure 21. France In Vivo Pharmacology Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. In Vivo Pharmacology Revenue, (US$, Mn), 2018-2029
Figure 23. Italy In Vivo Pharmacology Revenue, (US$, Mn), 2018-2029
Figure 24. Russia In Vivo Pharmacology Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries In Vivo Pharmacology Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux In Vivo Pharmacology Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia In Vivo Pharmacology Revenue Market Share, 2018-2029
Figure 28. China In Vivo Pharmacology Revenue, (US$, Mn), 2018-2029
Figure 29. Japan In Vivo Pharmacology Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea In Vivo Pharmacology Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia In Vivo Pharmacology Revenue, (US$, Mn), 2018-2029
Figure 32. India In Vivo Pharmacology Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America In Vivo Pharmacology Revenue Market Share, 2018-2029
Figure 34. Brazil In Vivo Pharmacology Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina In Vivo Pharmacology Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa In Vivo Pharmacology Revenue Market Share, 2018-2029
Figure 37. Turkey In Vivo Pharmacology Revenue, (US$, Mn), 2018-2029
Figure 38. Israel In Vivo Pharmacology Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia In Vivo Pharmacology Revenue, (US$, Mn), 2018-2029
Figure 40. UAE In Vivo Pharmacology Revenue, (US$, Mn), 2018-2029
Figure 41. Charles River In Vivo Pharmacology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. The Jackson Laboratory In Vivo Pharmacology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Syngene In Vivo Pharmacology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Evotec In Vivo Pharmacology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Pharmaron In Vivo Pharmacology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Aurigene Pharmaceutical In Vivo Pharmacology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Jubilant Biosys In Vivo Pharmacology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Labcorp In Vivo Pharmacology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Inotiv In Vivo Pharmacology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Takeda Pharmaceutical In Vivo Pharmacology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. EXUMA Biotech In Vivo Pharmacology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Novartis In Vivo Pharmacology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Be Biopharma In Vivo Pharmacology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Alderley Oncology In Vivo Pharmacology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Sygnature Discovery In Vivo Pharmacology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. GenScript ProBio In Vivo Pharmacology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Zai Lab In Vivo Pharmacology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Sinclair Research In Vivo Pharmacology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Eli Lilly In Vivo Pharmacology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Gubra In Vivo Pharmacology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



★調査レポート[世界の生体内薬理学市場予測2023-2029：動物疾患モデル、生体外薬理学およびバイオマーカー、PD/PK、その他] (コード：MMG23LY8808)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の生体内薬理学市場予測2023-2029：動物疾患モデル、生体外薬理学およびバイオマーカー、PD/PK、その他]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の安全性薬理学市場予測2023-2029：呼吸器系、中枢神経系、循環器系、医療機器安全性評価、天然物安全性評価、その他
  • 世界の生体内イメージング試薬市場予測2023-2029：ルシフェリン、セレンテラジン
  • 世界のデフォーカスミラー市場予測2023-2029：周辺部デフォーカス、多点デフォーカス
  • 世界の医薬品安定性試験チャンバー市場予測2023-2029：可動型安定性試験チャンバー、卓上型安定性試験チャンバー
  • 世界の医薬品用プルラン市場予測2023-2029：高純度プルラン、通常プルラン

    • ◆H&Iグローバルリサーチのお客様（例）◆